. 2012 Oct 10;1(1):131–140. doi: 10.1016/j.nicl.2012.10.001

Table 2.

Go/no-go task performance and functional data for control and ADHD subjects.

	Control		ADHD
	Control		1st day pre-medication				Post-placebo				Post-MPH
	Mean	SD	Mean	SD	t	p	Mean	SD	t	p	Mean	SD	t	p
ACC for go trials (%)	96.5	5.48	86.2	21.9	1.829	0.085^ns	85.3	20.2	2.14	0.047^ns	92.3	12.0	1.266	0.219^ns
ACC for no-go trials (%)	95.2	4.52	86.6	11.9	2.688	0.014^⁎	86.5	8.46	3.634	0.001^⁎⁎	89.5	8.51	2.347	0.028^ns
RT for correct go trials (ms)	421.4	57.5	385.5	96.8	1.275	0.214^ns	377.0	83.6	1.753	0.091^ns	404.9	47.9	0.881	0.386^ns
Oxy-Hb right CH10 (mM·mm)	0.075	0.074	0.008	0.084	2.374	0.024^⁎	0.001	0.087	2.586	0.015^⁎	0.077	0.060	− 0.110	0.916^ns

Performance data (ACC and RT) is presented for go and no-go trial data from go/no-go blocks. Oxy-Hb values for right CH10 are presented as functional data. For ADHD subjects, data for 1st day pre-medication, post-medication of placebo and MPH are shown. t-value, p-value and statistical significance were the results of t-tests between control and each ADHD condition. Abbreviations: SD, standard deviation; t, t-value; p, p-value. Statistical significances are presented as follows: ^⁎, p < 0.05; ^⁎⁎, p < 0.01; and ns, not significant.